Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245499 · ClinicalTrials.gov registry record · NA
Aging Brain Care Virtual Program
A NA study of Alzheimer Disease and Dementia, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 989
- Enrollment target
- 1
- Study location
NCT06245499: Completed NA study of Alzheimer Disease and Dementia, sponsored by Indiana University.
NCT06245499 is a NA study of Alzheimer Disease and Dementia that has completed, run by Indiana University. The registered enrollment target is 989 participants, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06245499, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 989 participants
- Enrollment target
- 1
- Study location
Study Summary
The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which patient and caregiver needs are identified during visits using validated assessment tools and addressed with standardized protocols. Protocols include management of behavioral/psychological symptoms of dementia, caregiver stress, medication management, comorbidity management and advance care planning.
Primary Outcome
Total count of emergency department encounters per patient
Conditions Studied
Interventions
- BEHAVIORAL Aging Brain Care Virtual Program
Study Locations (1)
Indiana
- Regenstrief Institute, Inc. - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 989 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What the finished NCT06245499 record still lists
NCT06245499 is an interventional study that assigns participants to a tested intervention. The registered 989 participants enrollment target is mid-sized for trials with a published cap, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Aging Brain Care Virtual Program is the first listed.
NCT06245499 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06245499 about?
NCT06245499 is a clinical study titled "Aging Brain Care Virtual Program". The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which pat...
What is the current status of trial NCT06245499?
This trial is currently completed. It is a NA study. The enrollment target is 989 participants. The study started on 2024-03-11. Estimated completion is 2025-10-31.
What conditions does trial NCT06245499 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia.
What interventions are being tested in trial NCT06245499?
The interventions under investigation include: Aging Brain Care Virtual Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06245499?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06245499 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06245499's enrollment target sits among peer trials
989 34th of 306 higher than 273 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- NCT06883305 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI